Santiago Andres Trujillo Perez

Cardiorenal syndrome represents a complex clinical condition resulting from bidirectional interactions between cardiac and renal dysfunction and is particularly relevant in patients with multimorbidity, in whom heart failure, chronic kidney disease, diabetes mellitus, hypertension, obesity, and vascular disease frequently coexist. This study analyzed current evidence regarding emerging biomarkers, prognostic stratification, and integrated therapeutic approaches in adult patients with cardiorenal syndrome and multimorbidity. A structured integrative review based on the Scientific Method was conducted using contemporary clinical guidelines, scientific statements, randomized controlled trials, observational studies, and biomarker investigations. The analysis focused on conventional parameters and emerging biomarkers associated with glomerular filtration, tubular injury, myocardial stress, inflammation, and fibrosis. Cystatin C showed its greatest relevance as a complementary marker of glomerular function, while NGAL and KIM-1 were predominantly associated with tubular injury. NT-proBNP was mainly related to myocardial stress and congestion, whereas sST2 and galectin-3 provided additional information regarding inflammatory and fibrotic remodeling. Prognostic assessment demonstrated that declining estimated glomerular filtration rate, increased albuminuria, persistent congestion, recurrent heart failure decompensation, biomarker abnormalities, and greater multimorbidity burden were consistently associated with adverse cardiorenal outcomes. Therapeutic evidence from major randomized trials showed that sodium–glucose cotransporter-2 inhibitors significantly reduced major kidney and cardiovascular events across broad chronic kidney disease populations, while finerenone demonstrated complementary renal and cardiovascular benefits in patients with type 2 diabetes and chronic kidney disease. The findings support a transition from isolated organ-based evaluation toward a multidimensional cardiorenal framework integrating renal function, cardiovascular status, metabolic disease, biomarker profiles, and therapeutic response. Emerging biomarkers may improve biological phenotyping but should currently complement rather than replace established clinical variables. Integrated, multidisciplinary management involving internal medicine, cardiology, and nephrology may provide a more coherent approach to risk stratification and individualized treatment in patients with complex cardiorenal disease.

Anesthesia is a complex physiological intervention capable of producing significant neurophysiological and systemic alterations that influence perioperative and postoperative patient outcomes. Contemporary evidence suggests that anesthetic agents affect cortical connectivity, thalamocortical communication, neurotransmitter regulation, cardiovascular stability, respiratory physiology, inflammatory pathways, and metabolic homeostasis. The objective of this review was to analyze the neurophysiological and systemic effects of anesthesia and evaluate their implications for perioperative recovery, postoperative complications, and patient-centered outcomes. A narrative review methodology supported by the Scientific Method framework was employed. Scientific literature indexed in internationally recognized databases including PubMed, Scopus, ScienceDirect, and specialized anesthesiology journals was analyzed. The review focused on studies published between 2015 and 2025 involving neurophysiological mechanisms of anesthesia, postoperative neurocognitive disorders, hemodynamic instability, systemic physiological alterations, perioperative brain health, and individualized anesthetic management strategies. The analyzed evidence demonstrated that anesthesia produces coordinated alterations involving neural networks, organ perfusion, inflammatory activation, respiratory dynamics, and metabolic regulation. Excessive anesthetic depth was associated with increased postoperative delirium and cognitive dysfunction, particularly among elderly and vulnerable patients. Intraoperative hypotension demonstrated a strong relationship with postoperative organ dysfunction and perioperative morbidity. Furthermore, individualized strategies such as electroencephalography-guided anesthesia, regional anesthesia, multimodal analgesia, and precision-based hemodynamic management were associated with improved recovery profiles and better postoperative outcomes.